Cancer Blog
- Dr. Robert Nagourney -

Dr. Robert A. Nagourney, MD

Breakthrough for Young Patients with a Rare Form of Liver Cancer

Extremely rare liver cancer that mostly affects people in their twenties associated with a gene rearrangement, mostly lethal, until now.

Dr. Robert A. Nagourney, MD

For Medical Oncology, Déjà Vu All Over Again

Patients are being encouraged to contact the researchers to get biopsies and help take charge of their disease.

Dr. Robert A. Nagourney, MD

Nagourney Cancer Institute: 20-year Experience in 10,000 Patients

At the 2023 American Association for Cancer Research meeting in Orlando, we reported results of ex vivo analysis of programmed cell death.

Dr. Robert A. Nagourney, MD

A Year-End Reflection

2022 Reflection. Among our most important accomplishments in 2022 was the installation of a world-class Mass Spectrometry research program.

Dr. Robert A. Nagourney, MD

Gastric (Stomach) Cancer: A Call for Patient Selection

Gastric (stomach) cancer is the fourth most common cancer worldwide with more than 930,000 diagnoses and 800,000 deaths attributed to...

Dr. Robert A. Nagourney, MD

The Information Disconnect - Genomics vs Human Cancer Biology

I recently had an interesting conversation with a physician regarding her patient with an aggressive breast cancer. A portion of tumor...

Dr. Robert A. Nagourney, MD

Functional Profiling Identifies Accurate Genomic Findings

The 2013 American Society of Clinical Oncology annual meeting, held May 31 – June 1, in Chicago, afforded the opportunity to report three...

Dr. Robert A. Nagourney, MD

Personalized Cancer Care: N-of-1

The New York Yankees catcher Yogi Berra famous quote, “Déjà vu all over again,” reminds me of the growing focus on the concept of “N-...

Dr. Robert A. Nagourney, MD

The Future of Cancer Research

The American Association for Cancer Research meeting held April 6 - 10 in Washington DC, provided a scientific perspective on oncologic...

Dr. Robert A. Nagourney, MD

Cancer as a Metabolic Disorder

I received an inquiry via Twitter “Has anyone thought about using a sugar medium (similar to PET scans) to deliver chemo drugs?” Although...